期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Radiotherapy combined with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma–a prospective clinical trial
1
作者 Ling Cai Mengzhong Liu +6 位作者 xiushen wang Mofa Gu Hui Liu Qun Li Nianji Cui Guohui Li Jinqing Li 《The Chinese-German Journal of Clinical Oncology》 CAS 2008年第2期64-68,共5页
Objective: This study evaluated the therapeutic effect of external beam radiotherapy (RT) combined with trans- catheter arterial chemoembolization (TACE) on the patients with unresectable hepatocellular carcinoma (HCC... Objective: This study evaluated the therapeutic effect of external beam radiotherapy (RT) combined with trans- catheter arterial chemoembolization (TACE) on the patients with unresectable hepatocellular carcinoma (HCC). Methods: From June 1994 to April 2002, 114 patients with unresectable HCC were nonrandomized prospectively stepped into our study. All patients received TACE as initial therapy, except 54 also received combination therapy with external beam therapy. Sur- vival failure patterns were analyzed and compared between the two groups. Results: Overall survival rates in the patients in the radiotherapy group were 65%, 47%, 38% at 1, 2, 3 years, respectively, improved over the non-radiotherapy group rates of 54%, 36.5%, 18% at 1, 2, 3 years, respectively. There was significant difference between two groups (P < 0.05). The survival rates correlated with tumor size, number of tumors, and portal vein embolus. Conclusion: TACE combined with RT is a more effective treatment than TACE alone in patients with unresectable HCC. 展开更多
关键词 RADIOTHERAPY transcatheter arterial chemoembolization hepatocellular carcinoma
暂未订购
The role of radiotherapy in 74 patients with dermatofibrosarcoma protuberans
2
作者 xiushen wang Mengzhong Liu +1 位作者 Hui Liu Nianji Cui 《The Chinese-German Journal of Clinical Oncology》 CAS 2006年第6期454-457,共4页
Objective:To study treatment and prognostic factor in 74 patients with dermatofibrosarcoma protuberans.Meth-ods:From August 1990 to November 1999,74 patients with dermatofibrosarcoma protuberans(DFSP)confirmed by path... Objective:To study treatment and prognostic factor in 74 patients with dermatofibrosarcoma protuberans.Meth-ods:From August 1990 to November 1999,74 patients with dermatofibrosarcoma protuberans(DFSP)confirmed by pathology were treated in Cancer Hospital of Sun Yat-sen University.72 cases were given wide excision and 2 cases were given local exci-sion.All of 74 cases,52 cases had surgical resection alone,and 22 cases had surgical resection combined with radiotherapy.Total dose of radiotherapy was 50-70 Gy.Results:The rate of recurrence was 36.1% for all patients.The 5-year recurrence-free survival(RFS)rate was 66%.The 5-year recurrence-free survival rates for resection alone and combined with radiotherapy were 58% and 90%,respectively(P=0.0187).The 5-year recurrence-free survival rates for positive microscopic margins and negative microscopic margins were 57% and 75%,respectively(P=0.0468).Conclusion:Post-operation radiotherapy is an effective treatment to decrease the recurrence rate for the patients with positive microscope,or the patients without suitable surgical treatment. 展开更多
关键词 dermatofibrosarcoma protuberans (DFSP) RADIOTHERAPY wide excision
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部